WO2005041894A3 - Compositions et methodes permettant de traiter, de prevenir, de supprimer et d'inhiber la douleur - Google Patents
Compositions et methodes permettant de traiter, de prevenir, de supprimer et d'inhiber la douleur Download PDFInfo
- Publication number
- WO2005041894A3 WO2005041894A3 PCT/US2004/036417 US2004036417W WO2005041894A3 WO 2005041894 A3 WO2005041894 A3 WO 2005041894A3 US 2004036417 W US2004036417 W US 2004036417W WO 2005041894 A3 WO2005041894 A3 WO 2005041894A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reversing
- compositions
- treating
- preventing
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne une composition permettant de traiter, de prévenir, de supprimer et d'inhiber la douleur, qui comprend un inhibiteur de nitration. Lesdites compositions peuvent avoir un effet d'inhibition de NOS, d'inhibition de système de génération de NO, de désactivation de NO, et combiner ces effets.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51616603P | 2003-10-31 | 2003-10-31 | |
US60/516,166 | 2003-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005041894A2 WO2005041894A2 (fr) | 2005-05-12 |
WO2005041894A3 true WO2005041894A3 (fr) | 2006-08-31 |
Family
ID=34549495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/036417 WO2005041894A2 (fr) | 2003-10-31 | 2004-10-31 | Compositions et methodes permettant de traiter, de prevenir, de supprimer et d'inhiber la douleur |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005041894A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916910A (en) * | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
US6093743A (en) * | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
-
2004
- 2004-10-31 WO PCT/US2004/036417 patent/WO2005041894A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916910A (en) * | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
US6093743A (en) * | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
Also Published As
Publication number | Publication date |
---|---|
WO2005041894A2 (fr) | 2005-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004105700A3 (fr) | Composes, procedes et compositions pharmaceutiques destines a l'inhibition de la parp | |
WO2001005393A3 (fr) | Traitement de douleurs chroniques au moyen d'inhibiteurs de mek | |
ZA200503967B (en) | Agent for preventing or treating neuropathy | |
WO2006073457A3 (fr) | Composes bioactifs et procedes de leur utilisation | |
WO2003105840A3 (fr) | Inhibiteurs de sphingosine kinase | |
WO2002072031A3 (fr) | Composes de tetracycline substitue utilises en tant qu'antifongiques synergiques | |
WO2005118511A3 (fr) | Composes, compositions et methodes permettant de stabiliser la transthyretine et d'inhiber un mauvais repliement de la transthyretine | |
WO2004073623A3 (fr) | Traitement d'etats pathologiques associes a la biodisponibilite reduite de l'oxyde nitrique, y compris des etats pathologiques causes par l'activite elevee de l'arginase | |
WO2004080391A3 (fr) | Nouveaux agents antibacteriens | |
MXPA03003314A (es) | Compuestos de c-nitrosoanilina y sus mezclas como inhibidores de polimerizacion. | |
WO2001017543A3 (fr) | Compositions et procedes permettant la prevention ou le traitement du cancer et de la perte osseuse associee au cancer | |
WO1998036730A3 (fr) | Compositions de traitement de l'acne rosacee | |
WO2004049907A3 (fr) | Compositions et méthodes de traitement de greffons | |
WO2005023191A3 (fr) | Procedes et compositions associes aux produits terminaux de la glycation avancee pour le traitement de la lesion glomerulaire | |
WO2007022042A3 (fr) | Composes organiques | |
WO2004087066A3 (fr) | Inhibiteurs de hif-1 | |
WO2001087287A3 (fr) | Composes actifs sur le plan pharmaceutiques et procedes d'utilisation | |
WO2005039626A3 (fr) | Procedes et compositions a utiliser pour le traitement des diabetes | |
ZA200502464B (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome. | |
WO2003015797A8 (fr) | Compositions assurant le traitement et la prevention de douleurs et d'inflammations a l'aide d'un inhibiteur selectif de cyclooxygenase-2 et de glucosamine | |
WO2005000208A3 (fr) | Therapie combinee pour le traitement des neoplasmes | |
AU2003249181A1 (en) | Methods for treating or preventing ischemic injury | |
WO2005041904A3 (fr) | Inhibiteurs de la protease de coronavirus et procedes de leur utilisation | |
WO2004034961A3 (fr) | Antimicrobiens et leurs utilisations | |
WO2001028493A3 (fr) | Inhibiteurs a petite molecule de la necrose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
122 | Ep: pct application non-entry in european phase |